UnknownPhase 4

The Impact of Vitamin on the Clinical Course in Cases Infected by Novel H1N1 Influenza Virus A

South Korea180 participantsStarted 2009-12

Plain-language summary

Influenza continues to inflict an important burden on health-care systems. The 2009 H1N1 influenza virus first appeared in Mexico and the United States in March and April 2009 and has swept the globe with unprecedented speed. The aim of this study is to evaluate effect of supplement vitamin on the clinical course of patients with acute respiratory illness suspected novel H1N1 infection.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age \> 20 years * Acute respiratory illness suspected H1N1 infection * Acute febrile respiratory illness(BT \> 37.8) and throat pain or cough or nasal congestion Exclusion Criteria: * Pregnancy * Hypersensitivity to vitamin A * History of liver disease or renal disease * Urinary stone disease

What they're measuring

change of symptom score

Timeframe: 1 week after initial visit

Trial details

NCT IDNCT01127282

SponsorSeoul National University Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2010-06

Contact for this trial

Chang-Hoon Lee, MD

+82- 2- 870- 2232 kauri670@gmail.com

View on ClinicalTrials.gov More H1N1 Influenza trials